Designing Human m1 Muscarinic Receptor-Targeted Hydrophobic Eigenmode Matched Peptides As Functional Modulators

Biophysical Journal

Volumn 86, Issue 3, 2004, Pages 1308-1331

  Selz, Karen A ^a,b,c   Mandell, Arnold J ^a,b,c   Shlesinger, Michael F ^a   Arcuragi, Vani ^b   Owens, Michael J ^b  

^a Cielo Institute   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ATROPINE; BETA LACTAMASE; CARBACHOL; CHAPERONIN; COAT PROTEIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GAP JUNCTION PROTEIN; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; NEUROPEPTIDE; NICOTINIC RECEPTOR; OXOTREMORINE; POLYPEPTIDE; PORIN; SNAKE VENOM; LIGAND; PEPTIDE;

ACIDIFICATION; ALGORITHM; ALLOSTERISM; ALPHA HELIX; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BETA CHAIN; CHO CELL; CONTROLLED STUDY; DRUG DESIGN; HYDROGEN BOND; HYDROPHOBICITY; NONHUMAN; PKA; PROTEIN FOLDING; SIGNAL PROCESSING; ANIMAL; BINDING SITE; CHEMICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; CRICETULUS; DRUG DELIVERY SYSTEM; HAMSTER; HUMAN; METABOLISM; METHODOLOGY; PROTEIN BINDING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; SERPENTES;

ALGORITHMS; ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; HYDROPHOBICITY; LIGANDS; MODELS, CHEMICAL; PEPTIDES; PROTEIN BINDING; RECEPTOR, MUSCARINIC M1; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN;

EID: 1542375375     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(04)74204-6     Document Type: Article

References (244)

1. 2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J. Biol. Chem. 271:1748-1755.
2. Adem, A., M. Jolkkonen, N. Bogdanovic, A. Islam, and E. Karlsson. 1997. Localization of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res. Bull. 44:597-601.
3. Adem, A., and E. Karlsson. 1997. Muscarinic receptor subtype selective toxins. Life Sci. 60:1069-1076.
4. Anfinsen, C. B. 1973. Principles that govern the folding of protein chains. Science. 181:223-230.
5. Bartus, R. T., R. L. Dean 3rd, B. Beer, and A. S. Lippa. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:408-414.
6. Bashford, D., and D. A. Case. 2000. Generalized born models of macromolecular solvation effects. Annu. Rev. Phys. Chem. 51:129-152.
7. Baxter, G. T., M. L. Young, D. L. Miller, and J. C. Owicki. 1994. Using microphysiometry to study the pharmacology of exogenously expressed m1 and m3 muscarinic receptors. Life Sci. 55:573-583.
8. Beattie, J., J. H. Shand, C. Bums, and D. J. Flint. 1996a. Immunodominant regions of the extra-cellular domain of the bovine growth hormone receptor. Biochem. Soc. Trans. 24:307S.
9. Beattie, J., J. H. Shand, and D. J. Flint. 1996b. An immobilised peptide array identifies antibodies to a discontinuous epitope in the extracellular domain of the bovine growth hormone receptor. Eur. J. Biochem. 239:479-486.
10. Bendat, J. S. 1958. Principles and Applications of Random Noise Theory. John Wiley & Sons, New York.
11. Bendat, J. S., and A. G. Piersol. 1986. Random Data; Analysis and Measurement Procedures. Wiley-Interscience, New York.
12. Ben-Naim, A. 1980. Hydrophobic Interactions. Plenum, New York.
13. Birdsall, N. J., F. Cohen, S. Lazareno, and H. Matsui. 1995. Allosteric regulation of G-protein-linked receptors. Biochem. Soc. Trans. 23:108-111.
14. Birdsall, N. J., T. Farries, P. Gharagozloo, S. Kobayashi, D. Kuonen, S. Lazareno, A. Popham, and M. Sugimoto. 1997. Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci. 60:1047-1052.
15. Birdsall, N. J., E. C. Hulme, and J. M. Stockton. 1983. Muscarinic receptor subclasses: allosteric interactions. Cold Spring Harb. Symp. Quant. Biol. 48:53-56.
16. Birdsall, N. J., S. Lazareno, and H. Matsui. 1996. Allosteric regulation of muscarinic receptors. Prog. Brain Res. 109:147-151.
17. Blanc, J. P., J. W. Taylor, R. J. Miller, and E. T. Kaiser. 1983. Examination of the requirement for an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides. J. Biol. Chem. 258:8277-8284.
18. Bohm, H.-J., and G. Klebe. 1996. What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Angew Chem. Int. Ed. Engl. 35:2588-2614.
19. Bonner, T. I. 1989. New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. Suppl: 11-15.
20. Bonner, T. I., N. J. Buckley, A. C. Young, and M. R. Brann. 1987. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:527-532.
21. Box, G. E. P., and G. M. Jenkins. 1970. Time Series Analysis, Forecasting and Control. Holden-Day, San Francisco.
22. Branden, C., and J. Tooze. 1999. Introduction to Protein Structure, 2nd ed. Garland, New York.
23. Brillinger, D. 1981. Time Series: Data Analysis and Theory. Holden-Day, New York.
24. Broomhead, D. S., R. Jones, and G. P. King. 1987. Addenda and correction. J. Phys. A. 20:L563-L569.
25. Broomhead, D. S., and G. P. King. 1986. Extracting qualitative dynamics from experimental data. Physica D. 20:217-236.
26. Bruccoleri. R. E., E. Haber, and J. Novotny. 1988. Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature. 335:564-568.
27. Buck, K. J., and S. G. Amara. 1995. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48:1030-1037.
28. Buckley, N. J., T. I. Bonner, and M. R. Brann. 1988. Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8:4646-4652.
29. Buckley, N. J., T. I. Bonner, C. M. Buckley, and M. R. Brann. 1989. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:469-476.
30. Caflisch, A., and M. Karplus. 1994. Molecular dynamics simulation of protein denaturation: solvation of the hydrophobic cores and secondary structure of bamase. Proc. Natl. Acad. Sci. USA. 91:1746-1750.
31. Chalaskinski, G., and M. M. Szczesniak. 1994. Origins of structure and energetics of van der Waals cluster from ab initio calculations. Chem. Rev. 94:1723-1765.
32. Chen, C. J., and H. Okayama. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
33. Chothia, C. 1974. Hydrophobic bonding and accessible surface area in proteins. Nature. 248:338-339.
34. Chothia, C. 1975. Structural invariants in protein folding. Nature. 254:304-308.
35. Chothia, C., and J. Janin. 1975. Principles of protein-protein recognition. Nature. 256:705-708.
36. Chou, P. Y., and G. D. Fasman. 1974a. Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry. 13:211-222.
37. Chou, P. Y., and G. D. Fasman. 1974b. Prediction of protein conformation. Biochemistry. 13:222-245.
38. Christopoulos, A., and T. Kenakin. 2002. G protein-coupled receptor allosterisms and complexing. Pharmacol. Rev. 54:323-374.
39. Christopoulos, A., A. Lanzafame, and F. Mitchelson. 1998. Allosteric interactions at muscarinic cholinoceptors. Clin. Exp. Pharmacol. Physiol. 25:185-194.
40. Cornette, J. L., K. B. Cease, H. Margalit, J. L. Spouge, J. A. Berzofsky, and C. DeLisi. 1987. Hydrophobicity scales and computational techniques for detecting amphipathic structures in proteins. J. Mol. Biol. 195:659-685.
41. Cox, D. R., and D. V. Hinkley. 1974. Theoretical Statistics. Chapman and Hall, London.
42. Creighton, T. 1993. Proteins: Structures and Molecular Properties, 2nd ed. W. H. Freeman, New York.
43. Dal Toso, R., B. Sommer, M. Ewert, A. Herb, D. B. Pritchett, A. Bach, B. D. Shivers, and P. H. Seeburg. 1989. The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8:4025-4034.
44. Damasio, A. R., N. R. Graff-Radford, P. J. Eslinger, H. Damasio, and N. Kassell. 1985. Amnesia following basal forebrain lesions. Arch. Neurol. 42:263-271.
45. Daubechies, I. 1992. Ten Lectures on Wavelets. SIAM, Philadelphia.
46. Daune, M. 1998. Molecular Biophysics. Oxford University Press, Oxford.
47. Davis, K. L., L. J. Thal, E. R. Gamzu, C. S. Davis, R. F. Woolson, S. I. Gracon, D. A. Drachman, L. S. Schneider, P. J. Whitehouse, and T. M. Hoover. 1992. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N. Engl. J. Med. 327:1253-1259.
48. Deber, C. M., M. Glibowicka, and G. A. Woolley. 1990. Conformations of proline residues in membrane environments. Biopolymers. 29:149-157.
49. Diaz-Arrastia, R., T. Ashizawa, and S. H. Appel. 1985. Endogenous inhibitor of ligand binding to the muscarinic acetylcholine receptor. J. Neurochem. 44:622-628.
50. Dickinson-Anson, H., I. Aubert, F. H. Gage, and L. J. Fisher. 1998. Hippocampal grafts of acetylcholine-producing cells are sufficient to improve behavioral performance following a unilateral fimbria-fornix lesion. Neuroscience. 84:771-781.
51. Dill, K. A., S. Bromberg, K. Yue, K. M. Fiebig, D. P. Yee, P. D. Thomas, and H. S. Chan. 1995. Principles of protein folding-a perspective from simple exact models. Protein Sci. 4:561-602.
52. Dill, K. A., K. M. Fiebig, and H. S. Chan. 1993. Cooperativity in protein-folding kinetics. Proc. Natl. Acad. Sci. USA. 90:1942-1946.
53. Dorje, F., J. Wess, G. Lambrecht, R. Tacke, E. Mutschler, and M. R. Brann. 1991. Antagonist binding profiles of five cloned human huscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:727-733.
54. Duerson, K., R. Carroll, and D. Clapham. 1993. Alpha-helical distorting substitution disrupt coupling between m3 muscarinic receptor and G proteins. FEBS Lett. 324:103-108.
55. Dunker, A. K., E. Garner, S. Guilliot, P. Romero, K. Albrecht, J. Hart, Z. Obradovic, C. Kissinger, and J. E. Villafranca. 1998. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomput. 473-484.
56. Dunker, A. K., J. D. Lawson, C. J. Brown, R. M. Williams, P. Romero, J. S. Oh, C. J. Oldfield, A. M. Campen, C. M. Ratliff, K. W. Hipps, J. Ausio, M. S. Nissen, R. Reeves, C. Kang, C. R. Kissinger, R. W. Bailey, M. D. Griswold, W. Chiu, E. C. Garner, and Z. Obradovic. 2001. Intrinsically disordered protein. J. Mol. Graph. Model. 19:26-59.
57. Dunker, A. K., and Z. Obradovic. 2001. The protein trinity-linking function and disorder. Nat. Biotechnol. 19:805-806.
58. Dyson, H. J., and P. E. Wright. 2002a. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12:54-60.
59. Dyson, H. J., and P. E. Wright. 2002b. Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance. Adv. Prot. Chem. 62:311-340.
60. Edsall, J. T., and J. Wyman. 1958. Biophysical Chemistry. Academic Press, New York.
61. Ehlert, F. J. 1988. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33:187-194.
62. Ehlert, F. J., and F. M. Delen. 1990. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats. Mol. Pharmacol. 38:143-147.
63. Eisenberg, D., R. M. Weiss, and T. C. Terwilliger. 1984. The hydrophobic moment detects periodicity in protein hydrophobicity. Proc. Natl. Acad. Sci. USA. 81:140-144.
64. Ellis, J., J. Huyler, and M. R. Brann. 1991. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem. Pharmacol. 42:1927-1932.
65. Farge, M., J. C. R. Hunt, and J. C. Vassilicos. 1993. Wavelets, fractals and Fourier transforms: detection and analysis of structure. In Wavelets, Fractals and Fourier Transforms. M. Farge, J. C. R. Hunt, and J. C. Vassilicos, editors. Clarendon Press, Oxford. 1-38.
66. Fauchere, J.-L., and V. Pliska. 1983. Hydrophobic parameters of pi amino acid-side chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med. Chem.-Chim. Ther. 18:369-375.
67. Ferscht, A. 1985. Enzyme Structure and Mechanism, 2nd ed. Freeman, San Francisco.
68. Fetrow, J. S., J. S. Spitzer, B. M. Gilden, S. J. Mellender, T. J. Begley, B. J. Haas, and T. L. Boose. 1998. Structure, function, and temperature sensitivity of directed, random mutants at proline 76 and glycine 77 in omega-loop D of yeast iso-1-cytochrome c. Biochemistry. 37:2477-2487.
69. Fisher, L. J., H. K. Raymon, and F. H. Gage. 1993. Cells engineered to produce acetylcholine: therapeutic potential for Alzheimer's disease. Ann. N. Y. Acad. Sci. 695:278-284.
70. Flicker, C., R. Dean, R. T. Bartus, S. H. Ferris, and T. Crook. 1985. Animal and human memory dysfunctions associated with aging, cholinergic lesions, and senile dementia. Ann. N. Y. Acad. Sci. 444:515-517.
71. Franks, F. 1972. Water: A Comprehensive Treatise, Vol. 1. Plenum Press, New York.
72. Fraser, C. M., C. D. Wang, D. A. Robinson, J. D. Gocayne, and J. C. Venter. 1989. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36:840-847.
73. Fukunaga, K. 1990. Introduction to Statistical Pattern Recognition. Academic Press, New York.
74. Fukushima, D., S. Yokoyama, D. J. Kroon, F. J. Kezdy, and E. T. Kaiser. 1980. Chain length-function correlation of amphiphilic peptides. Synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I. J. Biol. Chem. 255:10651-10657.
75. Gething, M.-J. 1997. Guidebook to Molecular Chaperones and Protein-Folding Catalysts. Sambrook-Tooze-Oxford, Oxford.
76. Gibney, B. R., Y. Isogai, F. Rabanal, K. S. Reddy, A. M. Grosset, C. C. Moser, and P. L. Dutton. 2000. Self-assembly of heme A and heme B in a designed four-helix bundle: implications for a cytochrome c oxidase maquette. Biochemistry. 39:11041-11049.
77. Giuliani, A., R. Benigni, M. Colafranceschi, I. Chandrashekar, and S. M. Cowsik. 2003. Large contact surface interactions between proteins detected by time series analysis methods: Case study on C-phycocyanins. Proteins. 51:299-310.
78. Giuliani, A., R. Benigni, P. Sirabella, J. P. Zbilut, and A. Colosimo. 2000. Nonlinear methods in the analysis of protein sequences: a case study in rubredoxins. Biophys. J. 78:136-149.
79. Giuliani, A., R. Benigni, J. P. Zbilut, C. L. Webber, Jr., P. Sirabella, and A. Colosimo. 2002. Nonlinear signal analysis methods in the elucidation of protein sequence-structure relationships. Chem. Rev. 102:1471-1492.
80. Gnagey, A. L., M. Seidenberg, and J. Ellis. 1999. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol. Pharmacol. 56:1245-1253.
81. Godzik, A., and J. Skolnick. 1992. Sequence-structure matching in globular proteins: application to supersecondary and tertiary structure determination. Proc. Natl. Acad. Sci. USA. 89:12098-12102.
82. Goldbeter, A., and D. E. Koshland Jr. 1981. An amplified sensitivity arising from covalent modification in biological systems. Proc. Natl. Acad. Sci. USA. 78:6840-6844.
83. Golub, G. H., and C. F. Van Loan. 1993. Matrix Computations. Johns Hopkins Press, Baltimore.
84. Griffin, M. T., J. C. Hsu, D. Shehnaz, and F. J. Ehlert. 2003. Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination. Biochem. Pharmacol. 65:1227-1241.
85. Gronenbom, A. M., and G. M. Clore. 1994. Experimental support for the "hydrophobic zipper" hypothesis. Science. 263:536.
86. Grossman, A., and J. Morlet. 1984. Decomposition of Hardy functions into square integrable wavelets of constant shape. SIAM J. Math, Anal. 15:723-736.
87. Guevara, M. R., L. Glass, and A. Shrier. 1981. Phase locking, period-doubling bifurcations, and irregular dynamics in periodically stimulated cardiac cells. Science. 214:1350-1353.
88. Gunasekaran, K., H. A. Nagarajaram, C. Ramakrishnan, and P. Balaram. 1998. Stereochemical punctuation marks in protein structures: glycine and proline containing helix stop signals. J. Mol. Biol. 275:917-932.
89. Guner, O. F., editor. 1999. Pharmacophore, Perception, Development and Use in Drug Design. International University Line, La Jolla, CA.
90. Hall, D. A. 2000. Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation. Mol. Pharmacol. 58:1412-1423.
91. Heron, G. S., and M. I. Schimerlik. 1984. Protein composition of the atrial muscarinic acetylcholine receptor partially purified by wheat germ agglutinin affinity chromatography. Arch. Biochem. Biophys. 230:533-542.
92. Hirakawa, M., S. Muta, and S. Kuhara. 1999. The hydrophobic core of proteins predicted by wavelet analysis. Bioinformatics. 15:141-148.
93. Hoel, P. G. 1971. Introduction to Mathematical Statistics. Wiley, New York.
94. Housset, D., and J. C. Fontecilla-Camps. 1996. The structures and evolution of snake toxins of the three-finger folding type. In Protein Toxin Structure. M. W. Parker, editor. Springer, New York. 271-290.
95. Howl, J., and M. Wheatley. 1996. Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors. Biochem. J. 317:577-582.
96. Hruby, V. J., and R. S. Agnes. 1999. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. Biopolymers. 51:391-410.
97. Hu, J., and E. E. el-Fakahany. 1993. Allosteric interaction of dynorphin and myelin basic protein with muscarinic receptors. Pharmacology. 47:351-359.
98. Hu, J., S. Z. Wang, C. Forray, and E. E. el-Fakahany. 1992. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands. Mol. Pharmacol. 42:311-321.
99. Hulme, E. C. 1990. Muscarinic acetylcholine receptors: typical G-coupled receptors. Symp. Soc. Exp. Biol. 44:39-54.
100. Hulme, E. C., C. A. Curtis, K. M. Page, and P. G. Jones. 1995. The role of charge interactions in muscarinic agonist binding, and receptor-response coupling. Life Sci. 56:891-898.
101. Hulme, E. C., E. Kurtenbach, and C. A. Curtis. 1991. Muscarinic acetylcholine receptors: structure and function. Biochem. Soc. Trans. 19:133-138.
102. Huntly, J. J., W. Fast, S. J. Benkovic, D. C. Wright, and H. J. Dyson. 2003. Role of solvent-exposed tryptophan in the recognition and binding of antibiotic substrates for a metallo-beta-lactamase. Protein Sci. 12:1368-1375.
103. Ikeda, K., S. Kobayashi, M. Suzuki, K. Miyata, T. Yamada, and K. Honda. 1999. Ca2+ mobilization and activation of extracellular acidification by carbachol in acutely dispersed cells from guinea pig detrusor: fura 2 fluorometry and microphysiometry using the cytosensor. Life Sci. 65:1569-1577.
104. Irback, A., C. Peterson, and F. Potthast. 1996. Evidence for nonrandom hydrophobicity structures in protein chains. Proc. Natl. Acad. Sci. USA. 93:9533-9538.
105. Irback, A., and E. Sandelin. 2000. On hydrophobicity correlations in protein chains. Biophys. J. 79:2252-2258.
106. Israelachvili, J., and H. Wennerstrom. 1996. Role of hydration and water structure in biological and colloidal interactions. Nature. 379:219-225.
107. Israelachvilli, J. 1992. Intermolecular and Surface Forces, 2nd ed. Academic Press, San Diego.
108. Jakubik, J., L. Bacakova, E. E. El-Fakahany, and S. Tucek. 1997. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 52:172-179.
109. Jakubik, J., L. Bacakova, V. Lisa, E. E. el-Fakahany, and S. Tucek. 1996. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA. 93:8705-8709.
110. Janin, J. 1995. Protein-protein recognition. Prog. Biophys. Mol. Biol. 64:145-166.
111. Jerusalinsky, D., and A. L. Harvey. 1994. Toxins from mamba. venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 15:424-430.
112. Jerusalinsky, D., A. Harvey, E. Karlsson, and L. Potter. 1997. Workshop: the use of muscarinic toxins in the study of muscarinic receptors. Life Sci. 60:1161-1162.
113. Jolkkonen, M., A. Adem, U. Hellman, C. Wernstedt, and E. Karlsson. 1995. A snake toxin against muscarinic acetylcholine receptors: amino acid sequence, subtype specificity and effect on guinea-pig ileum. Toxicon. 33:399-410.
114. Kaiser, E. T., and F. J. Kezdy. 1983. Secondary structures of proteins and peptides in amphiphilic environments. (A review). Proc. Natl. Acad. Sci. USA. 80:1137-1143.
115. Kamtekar, S., J. M. Schiffer, H. Xiong, J. M. Babik, and M. H. Hecht. 1993. Protein design by binary patteming of polar and nonpolar amino acids. Science. 262:1680-1685.
116. Kashihara, K., E. V. Varga, S. L. Waite, W. R. Roeske, and H. I. Yamamura. 1992. Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes. Life Sci. 51:955-971.
117. Kauzmann, W. 1959. Some factors in the interpretation of protein denaturation. Adv. Protein Chem. 14:1-63.
118. Kennakin, T., and C. Boselli. 1989. Pharmacological discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic response in rat trachea. J. Pharmacol. Exp. Ther. 250:944-952.
119. Kozell, L. B., C. A. Machida, R. L. Neve, and K. A. Neve. 1994. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. J. Biol. Chem. 269:30299-30306.
120. Kriwacki, R. W., L. Hengst, L. Tennant, S. I. Reed, and P. E. Wright. 1996. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA. 93:11504-11509.
121. Krogh, A., B. Larsson, G. von Heijne, and E. L. Sonnhammer. 2001. Predicting transmembrane protein topology with a hidden Markov model. J. Mol. Biol. 305:567-580.
122. Kukhtina, V. V., C. Weise, T. A. Muranova, V. G. Starkov, P. Franke, F. Hucho, S. Wnendt, C. Gillen, V. I. Tsetlin, and Y. N. Utkin. 2000. Muscarinic toxin-like proteins from cobra venom. Eur. J. Biochem. 267:6784-6789.
123. Kuo, R. C., G. T. Baxter, L. Alajoki, D. L. Miller, J. M. Libby, and J. C. Owicki. 1993. A metabolic view of receptor activation in cultured cells following cryopreservation. Cryobiology. 30:386-395.
124. Kurtenbach, E., C. A. Curtis, E. K. Pedder, A. Aitken, A. C. Harris, and E. C. Hulme. 1990. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J. Biol. Chem. 265:13702-13708.
125. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
126. Lanzafame, A., A. Christopoulos, and F. Mitchelson. 1997. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors. J. Pharmacol. Exp. Ther. 282:278-285.
127. Lau, S. H., J. Rivier, W. Vale, E. T. Kaiser, and F. J. Kezdy. 1983. Surface properties of an amphiphilic peptide hormone and of its analog: corticotropin-releasing factor and sauvagine. Proc. Natl. Acad. Sci. USA. 80:7070-7074.
128. Lauffenburger, D. A., and J. J. Linderman. 1993. Receptors: Models for Binding, Trafficking and Signaling. Oxford University Press, New York.
129. Lazareno, S., and N. Birdsall. 1996. Quantitation of allosteric interactions. Trends Pharmacol. Sci. 17:443-444.
130. Lazaridis, T., and M. Karplus. 1997. "New view" of protein folding reconciled with the old through multiple unfolding simulations. Science. 278:1928-1931.
131. Lazovic, J. 1996. Selection of amino acid parameters for Fourier transform-based analysis of proteins. Comput. Appl. Biosci. 12:553-562.
132. Leckband, D. E., J. N. Israelachvili, F. J. Schmitt, and W. Knoll. 1992. Long-range attraction and molecular rearrangements in receptor-ligand interactions. Science. 255:1419-1421.
133. Leckband, D. E., F. J. Schmitt, J. N. Israelachvili, and W. Knoll. 1994. Direct force measurements of specific and nonspecific protein interactions. Biochemistry. 33:4611-4624.
134. Lee, N. H., and E. E. el-Fakahany. 1991. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 42:199-205.
135. Levey, A. I. 1996. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 93:13541-13546.
136. Liao, C. F., A. P. Themmen, R. Joho, C. Barberis, M. Bimbaumer, and L. Bimbaumer. 1989. Molecular cloning and expression of a fifth muscarinic acetylcholine receptor. J. Biol. Chem. 264:7328-7337.
137. Limbird, L. E. 1986. Cell Surface Receptors: A Short Course on Theory and Methods. Martinius Nijhoff Publishers, Boston.
138. Lin, Q., H. S. Park, Y. Hamuro, C. S. Lee, and A. D. Hamilton. 1998. Protein surface recognition by synthetic agents: design and structural requirements of a family of artificial receptors that bind to cytochrome c. Biopolymers. 47:285-297.
139. Lio, P., and M. Vannucci. 2000. Wavelet change-point prediction of transmembrane proteins. Bioinformatics. 16:376-382.
140. Lumry, R. 1995. On the interpretation of data from isothermal processes. Methods Enzymol. 259:628-720.
141. Ma, J., and M. Karplus. 1997. Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21. Proc. Natl. Acad. Sci. USA. 94:11905-11910.
142. Madan, R. N. 1993. All poles, maximum entropy spectra. In Maximum Entropy and Bayesian Methods. A. Mohananad-Djafaro and G. Demoments, editors. Kluwar, Dardrecht, The Netherlands. 49-54.
143. Makhatadze, G. I., and P. L. Privalov. 1993. Contribution of hydration to protein folding thermodynamics. I. The enthalpy of hydration. J. Mol. Biol. 232:639-659.
144. Makino, S., and I. D. Kuntz. 1997. Automated flexible ligand docking method and its application for data base search. J. Comput. Chem. 18:1812-1825.
145. Mallat, S. 1989. Multiresolution approximation and wavelets. Trans. Amer. Math. Soc. 315:69-88.
146. Manavalen, P., and P. K. Ponnuswamy. 1978. Hydrophobic character of amino acid residues in globular proteins. Nature. 275:673-674.
147. Mandell, A. J. 1983. From chemical homology to topological temperature: a notion relating the structure and function of polypeptides. In Synergetics of the Brain. E. Basar, H. Flohr, H. Haken, and A. J. Mandell, editors. Springer-Verlag, Berlin. 365-376.
148. Mandell, A. J. 1984. Non-equilibrium behavior of some brain enzymes and receptor systems. Annu. Rev. Pharmacol. Toxicol. 24:237-274.
149. Mandell, A. J. 1986. Prime times: the distribution of singularities in hydrophobic free energy of proteins. In Perspectives in Nonlinear Dynamics. M. F. Shlesinger, R. Cawley, A. W. Saenz, and W. Zachary, editors. World Scientific, Singapore. 259-278.
150. Mandell, A. J. 1987. The source and characteristics of normal modes in molecular biology. In Synergetics, Order and Chaos. M. G. Velarde, editor. World Scientific, Singapore. 351-367.
151. Mandell, A. J., M. J. Owens, K. A. Selz, W. N. Morgan, M. F. Shlesinger, and C. B. Nemeroff. 1998a. Mode matches in hydrophobic free energy eigenfunctions predict peptide-protein interactions. Biopolymers. 46:89-101.
152. Mandell, A. J., and P. V. Russo. 1981. Striatal tyrosine hydroxylase activity: multiple conformational kinetic oscillators and product concentration frequencies. J. Neurosci. 1:380-389.
153. Mandell, A. J., P. V. Russo, and B. W. Blomgren. 1987. Geometric universality in brain allosteric protein dynamics; complex hydrophobic transformation predicts mutual recognition by polypeptides and proteins. Ann. N. Y. Acad. Sci. 504:88-117.
154. Mandell, A. J., and K. A. Selz. 1997. Entropy conservation as h(T(μ)) approximately lambda(μ) (+)d(μ) in neurobiological dynamical systems. Chaos. 7:67-81.
155. Mandell, A. J., K. A. Selz, M. J. Owens, M. F. Shlesinger, B. Kinkead, D. A. Gutman, and B. S. Arguragi. 2003. Cellular and behavioral effects of D2 dopamine receptor hydrophobic eigenmode-targeted peptide ligands. Neuropsychopharmacology. 26:S98-S107.
156. Mandell, A. J., K. A. Selz, M. J. Owens, M. F. Shlesinger, D. A. Gutman, and V. Arcuragi. 2001. Hydrophobic mode-targeted, algorithmically designed peptide ligands as modulators of protein thermodynamic structure and function. In Drug-Receptor Thermodynamics: Introduction and Applications. R. Raffa, editor. Wiley & Sons, New York. 655-700.
157. Mandell, A. J., K. A. Selz, and M. Shlesinger. 1997a. Wavelet transformation of protein hydrophobicity sequences suggests their memberships in structural families. Physica A. 244:254-262.
158. Mandell, A. J., K. A. Selz, and M. F. Shlesinger. 1997b. Hydrophobic free energy eigenfunctions help define continuous wavelet transformations of amino acid sequences of protein families. Proc. Int. Sch. Physics "Enrico Fermi". 134:175-191.
159. Mandell, A. J., K. A. Selz, and M. F. Shlesinger. 1997c. Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions. Proc. Natl. Acad. Sci. USA. 94:13576-13581.
160. Mandell, A. J., K. A. Selz, and M. F. Shlesinger. 1998b. Transformational homologies in amino acid sequences suggest membership in protein families. J. Stat. Phys. 93:673-697.
161. Mandell, A. J., K. A. Selz, and M. F. Shlesinger. 2000a. Predicting peptide-receptor, peptide-protein and chaperone-protein binding using patterns in amino acid hydrophobic free energy sequences. J. Phys. Chem. B. 104:3953-3959.
162. Mandell, A. J., K. A. Selz, and M. F. Shlesinger. 2000b. Protein binding predictions from amino acid primary sequence hydrophobicity. J. Mol. Liq. 86:163-171.
163. Matsui, H., S. Lazareno, and N. J. Birdsall. 1995. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol. Pharmacol. 47:88-98.
164. May, R. M. 1974. Biological populations with nonoverlapping generations: stable points, stable cycles, and chaos. Science. 186:645-647.
165. McConnell, H. M., J. C. Owicki, J. W. Parce, D. L. Miller, G. T. Baxter, H. G. Wada, and W. Pitchford. 1992. The cytosensor microphysiometer: biological applications of silicon technology. Science. 257:1906-1912.
166. McKinney, M., and J. T. Coyle. 1991. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clin. Proc. 66:1225-1237.
167. Mijares, A., D. Lebesgue, J. Argibay, and J. Hoebeke. 1996. Anti-peptide antibodies sensitive to the "active" state of the B2-adrenergic receptor. FEBS Lett. 399:188-191.
168. 2-adrenoceptor antibody behave like antagonists. Mol. Pharmacol. 58:373-379.
169. Milner-White, E. J., and R. Poet. 1987. Loops, bulges, turns and hairpins in proteins. Trends Biochem. Sci. 12:189-192.
170. Monne, M., M. Hermansson, and G. von Heijne. 1999. A turn propensity scale for transmembrane helices. J. Mol. Biol. 288:141-145.
171. Mrzljak, L., A. I. Levey, S. Belcher, and P. S. Goldman-Rakic. 1998. Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey. J. Comp. Neurol. 390:112-132.
172. Murray, K. B., D. Gorse, and J. M. Thornton. 2002. Wavelet transforms for the characterization and detection of repeating motifs. J. Mol. Biol. 316:341-363.
173. Naylor, L., R. Woodward, S. Daniell, C. Coley, and P. Strange. 1995. Determinants of ligand binding at the D2 dopamine receptor. Biochem. Soc. Trans. 23:87-91.
174. Neve, K. A., and B. L. Wiens. 1995. Four ways of being an agonist: multiple sequence determinants of efficacy at D2 dopamine receptors. Biochem. Soc. Trans. 23:112-116.
175. Nilsson, I., and G. von Heijne. 1998. Breaking the camel's back: proline-induced turns in a model transmembrane helix. J. Mol. Biol. 284:1185-1189.
176. Nirenberg, M. J., J. Chan, R. A. Vaughan, G. R. Uhl, M. J. Kuhar, and V. M. Pickel. 1997. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J. Neurosci. 17:5255-5262.
177. Norris, J. D., L. A. Paige, D. J. Christensen, C. Y. Chang, M. R. Huacani, D. Fan, P. T. Hamilton, D. M. Fowlkes, and D. P. McDonnell. 1999. Peptide antagonists of the human estrogen receptor. Science. 285:744-746.
178. Nozaki, Y., and C. Tanford. 1971. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. J. Biol. Chem. 246:2211-2217.
179. Numa, S., K. Fukuda, T. Kubo, A. Maeda, I. Akiba, H. Bujo, J. Nakai, M. Mishina, and H. Higashida. 1988. Molecular basis of the functional heterogeneity of the muscarinic acetylcholine receptor. Cold Spring Harb. Symp. Quant. Biol. 53:295-301.
180. Olianas, M. C., A. Ingianni, C. Maullu, A. Adem, E. Karlsson, and P. Onali. 1999. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. J. Pharmacol. Exp. Ther. 288:164-170.
181. Olianas, M. C., C. Maullu, A. Adem, E. Mulugeta, E. Karlsson, and P. Onali. 2000. Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7). Br. J. Pharmacol. 131:447-452.
182. Ott, E., T. Sauer, and J. A. Yorke. 1994. Coping with Chaos. Wiley, New York.
183. Owens, M. J., W. N. Morgan, S. J. Plott, and C. B. Nemeroff. 1997. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J. Pharmacol. Exp. Ther. 283:1305-1322.
184. Palczewski, K., T. Kumasaka, T. Hori, C. A. Behnke, H. Motoshima, B. A. Fox, I. Le Trong, D. C. Teller, T. Okada, and R. E. Stenkamp. 2000. Crystal structure of rhodopsin: a G-protein coupled receptor. Science. 289:739-745.
185. Park, S., M. E. Johnson, and L. W. Fung. 2000. NMR analysis of secondary structure and dynamics of a recombinant peptide from the N-terminal region of human erythroid alpha-spectrin. FEBS Lett. 485:81-86.
186. Pashley, R. M., P. M. McGuiggan, B. W. Ninham, and D. F. Evans. 1985. Attractive forces between uncharged hydrophobic surfaces: direct measurement in aqueous solution. Science. 229:1088-1089.
187. Penel, S., R. G. Morrison, R. J. Mortishire-Smith, and A. J. Doig. 1999. Periodicity in alpha-helix lengths and C-capping preferences. J. Mol. Biol. 293:1211-1219.
188. Peralta, E. G., J. W. Winslow, G. L. Peterson, D. H. Smith, A. Ashkenazi, J. Ramachandran, M. I. Schimerlik, and D. J. Capon. 1987. Primary structure and biochemical properties of an M2 muscarinic receptor. Science. 236:600-605.
189. Perry, T. L., S. Hansen, and J. Kennedy. 1975. CSF amino acids and plasma-CSF amino acid ratios in adults. J. Neurochem. 24:587-589.
190. Press, W. H. B.P. Flannery, S. A. Teukolsky, and W. T. Vetterling. 1988. Numerical Recipes in C; The Art of Scientific Computing. Cambridge University Press, Cambridge.
191. Priestly, M. D. 1981. Spectral Analysis and Time Series. Academic Press, San Diego.
192. Privalov, P. L. 1987. Protein stability and hydrophobic interactions. Biofizika. 32:742-760.
193. Privalov, P. L. 1989. Thermodynamic problems of protein structure. Annu. Rev. Biophys. Biophys. Chem. 18:47-69.
194. Privalov, P. L., and S. J. Gill. 1988. Stability of protein structure and hydrophobic interaction. Adv. Protein Chem. 39:191-234.
195. Proska, J., and S. Tucek. 1995. Competition between positive and negative allosteric effectors on muscarinic receptors. Mol. Pharmacol. 48:696-702.
196. Ptitsyn, O. B., V. E. Bychkova, and V. N. Uversky. 1995. Kinetic and equilibrium folding intermediates. Philos. Trans. R. Soc. Lond. B Biol. Sci. 348:35-41.
197. Qu, Y., J. C. Rogers, S. F. Chen, K. A. McCormick, T. Scheuer, and W. A. Catterall. 1999. Functional roles of the extracellular segments of the sodium channel alpha subunit in voltage-dependent gating and modulation by beta1 subunits. J. Biol. Chem. 274:32647-32654.
198. Rackovsky, S. 1998. "Hidden" sequence periodicities and protein architecture. Proc. Natl. Acad. Sci. USA. 95:8580-8584.
199. Radzicka, A., and R. Wolfenden. 1988. Comparing the polarities of the amino acids: side-chain distribution coefficients between the vapor phase, cyclohexane, 1-octanol and neutral aqueous solution. Biochemistry. 27:1664-1670.
200. Richards, F. M., and T. Richmond. 1977. Solvents, interfaces and protein structure. Ciba Found. Symp. 60:23-45.
201. Romero, P., Z. Obradovic, C. R. Kissinger, J. E. Villafranca, E. Garner, S. Guilliot, and A. K. Dunker. 1998. Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput. 437-448.
202. Romero, P., Z. Obradovic, X. Li, E. C. Garner, C. J. Brown, and A. K. Dunker. 2001. Sequence complexity of disordered protein. Proteins. 42:38-48.
203. Rondard, P., and H. Bedouelle. 2000. Mutational scanning of a hairpin loop in the tryptophan synthase beta-subunit implicated in allostery and substrate channeling. Biol. Chem. 381:1185-1193.
204. Rose, G. D. 1978. Prediction of chain turns in globular proteins on a hydrophobic basis. Nature. 272:586-590.
205. Rose, G. D., and S. Roy. 1980. Hydrophobic basis of packing in globular proteins. Proc. Natl. Acad. Sci. USA. 77:4643-4647.
206. Rose, G. D., and D. B. Wetlaufer. 1977. The number of turns in globular proteins. Nature. 268:769-770.
207. Russo, P. V., and A. J. Mandell. 1984. Metrics from nonlinear dynamics adapted for characterizing the behavior of nonequilibrium enzymatic rate functions. Anal. Biochem. 139:91-99.
208. Sandak, B., R. Nussinov, and H. J. Wolfson. 1998. A method for biomolecular structural recognition and docking allowing conformational flexibility. J. Comput. Biol. 5:631-654.
209. Sanger, F. 1952. Amino acid sequences are unique in polypeptides and proteins. Adv. Prot. Chem. 7:1-67.
210. Schiffer, M., and A. B. Edmundson. 1967. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys. J. 7:121-135.
211. Schwartz, T. W., and M. M. Rosenkilde. 1996. Is there a "lock" for all agonist "keys" in 7TM receptors? Trends Pharmacol. Sci. 17:213-216.
212. Selz, K. A., and A. J. Mandell. 1991. Bernoulli partition-equivalence of intermittent neuronal discharge patterns. Int J. Bifurcat. Chaos. 1:717-722.
213. Selz, K. A., A. J. Mandell, C. M. Anderson, W. P. Smotherman, and M. Teicher. 1995. Distribution of local Mandelbrot-Hurst exponents: motor activity in cocaine treated fetal rats and manic depressive patients. Fractals. 3:893-904.
214. Selz, K. A., A. J. Mandell, and M. F. Shlesinger. 1998. Hydrophobic free energy eigenfunctions of pore, channel, and transporter proteins contain beta-burst patterns. Biophys. J. 75:2332-2342.
215. Sharp, K. A., A. Nicholls, R. F. Fine, and B. Honig. 1991a. Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science. 252:106-109.
216. Sharp, K. A., A. Nicholls, R. Friedman, and B. Honig. 1991b. Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models. Biochemistry. 30:9686-9697.
217. Shoemaker, B. A., J. Wang, and P. G. Wolynes. 1997. Structural correlations in protein folding funnels. Proc. Natl. Acad. Sci. USA. 94:777-782.
218. Shu, W., J. Liu, H. Ji, L. Radigen, S. Jiang, and M. Lu. 2000. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides. Biochemistry. 39:1634-1642.
219. Simpson, M. M., J. A. Ballesteros, V. Chiappa, J. Chen, M. Suehiro, D. S. Hartman, T. Godel, L. A. Snyder, T. P. Sakmar, and J. A. Javitch. 1999. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. Mol. Pharmacol. 56:1116-1126.
220. Spencer, R. W. 1998. High-throughput screening of historic collections: observations on file size, biological targets, and file diversity. Biotechnol. Bioeng. 61:61-67.
221. Stahl, M., and H. J. Bohm. 1998. Development of filter functions for protein-ligand docking. J. Mol. Graph. Model. 16:121-132.
222. Stillinger, F. H. 1977. Theoretical approaches to the intermolecular nature of water. Philos. Trans. R. Soc. Lond. B Biol. Sci. 278:97-112.
223. Strang, G. 1993. Wavelet transformation versus Fourier transformation. Bull. Am. Math Soc. 28:288-305.
224. Takeuchi, Y., E. F. Shands, D. D. Beusen, and G. R. Marshall. 1998. Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor. J. Med. Chem. 41:3609-3623.
225. Tanford, C. 1980. The Hydrophobic Effect. Wiley, New York.
226. Tsao, Y. H., D. F. Evans, and H. Wennerstrom. 1993. Long-range attractive force between hydrophobic surfaces observed by atomic force microscopy. Science. 262:547-550.
227. Tucek, S., and J. Proska. 1995. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:205-212.
228. Ulloa-Aguirre, A., and P. M. Conn. 2000. G protein-coupled receptors and G proteins. In Principles of Molecular Recognition. P. M. Conn and A. R. Means, editors. Humana, Totowa, NJ. 3-25.
229. Unwin, N. 1993. Nicotinic acetylcholine receptor at 9 Å resolution. J. Mol. Biol. 229:1101-1124.
230. Vaughan, R. A., J. D. Gaffaney, J. R. Lever, M. E. Reith, and A. K. Dutta. 2001. Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains. Mol. Pharmacol. 59:1157-1164.
231. von Heijne, G. 1991. Proline kinks in transmembrane alpha-helices. J. Mol. Biol. 218:499-503.
232. Wang, H. L., K. Ohno, M. Milone, J. M. Brengman, A. Evoli, A. P. Batocchi, L. T. Middleton, K. Christodoulou, A. G. Engel, and S. M. Sine. 2000. Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J. Gen. Physiol. 116:449-462.
233. Watanabe, M., J. Rosenbusch, T. Schirmer, and M. Karplus. 1997. Computer simulations of the OmpF porin from the outer membrane of Escherichia coli. Biophys. J. 72:2094-2102.
234. Wess, J., T. I. Bonner, F. Dorje, and M. R. Brann. 1990. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol. Pharmacol. 38:517-523.
235. Wickerhauser, M. V. 1994. Adapted Wavelet Analysis from Theory to Software. A. K. Peters, Wellesley, MA.
236. Wold, S. 1965. Bibliography on Time-Series and Stochastic Processes. Oliver and Boyd, Edinburgh.
237. Wood, M. D., K. L. Murkitt, M. Ho, J. M. Watson, F. Brown, A. J. Hunter, and D. N. Middlemiss. 1999. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry. Br. J. Pharmacol. 126:1620-1624.
238. Woodward, R., S. J. Daniell, P. G. Strange, and L. H. Naylor. 1994. Structural studies on D2 dopamine receptors: mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs. J. Neurochem. 62:1664-1669.
239. Wouters, J., G. Baudoux, E. Depiereux, and P. Fischer. 2000. Analysis of transmembrane helices in protein sequences using wavelet-based hydropathic plots. fischer@math.u-bordeaux.fr.
240. Wright, P. E., and H. J. Dyson. 1999. Intrinsically unstructured proteins: reassessing the protein structure-function paradigm. J. Mol. Biol. 293:321-331.
241. Yaglom, A. M. 1962. An Introduction to the Theory of Stationary Random Functions. Prentice-Hall, Englewood Cliffs, NJ.
242. Yang, A. S., and B. Honig. 1995. Free energy determinants of secondary structure formation: I. Alpha-helices. J. Mol. Biol. 252:351-365.
243. Zamyatnin, A. A. 1984. Amino acid, peptide and protein volume in solution. Annu. Rev. Biophys. Bioeng. 13:145-165.
244. Zysk, J. R., and W. R. Baumbach. 1998. Homogeneous pharmacologic and cell-based screens provide diverse strategies in drug discovery: somatostatin antagonists as a case study. Comb. Chem. High Throughput Screen. 1:171-183.